185 related articles for article (PubMed ID: 32330381)
41. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
42. A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapy.
Qiu L; Chen T; Öçsoy I; Yasun E; Wu C; Zhu G; You M; Han D; Jiang J; Yu R; Tan W
Nano Lett; 2015 Jan; 15(1):457-63. PubMed ID: 25479133
[TBL] [Abstract][Full Text] [Related]
43. Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia.
Olivas-Aguirre M; Pottosin I; Dobrovinskaya O
J Leukoc Biol; 2019 May; 105(5):935-946. PubMed ID: 30698851
[TBL] [Abstract][Full Text] [Related]
44. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
Chen Y; Deng Y; Zhu C; Xiang C
Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561
[TBL] [Abstract][Full Text] [Related]
45. Light-Induced Redox-Responsive Smart Drug Delivery System by Using Selenium-Containing Polymer@MOF Shell/Core Nanocomposite.
Luo Z; Jiang L; Yang S; Li Z; Soh WMW; Zheng L; Loh XJ; Wu YL
Adv Healthc Mater; 2019 Aug; 8(15):e1900406. PubMed ID: 31183979
[TBL] [Abstract][Full Text] [Related]
46. Construction of biomimetic silver nanoparticles in the treatment of lymphoma.
Zhao Q; Sun XY; Wu B; Shang Y; Huang X; Dong H; Liu H; Chen W; Gui R; Li J
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111648. PubMed ID: 33321684
[TBL] [Abstract][Full Text] [Related]
47. Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodies.
Liu R; Jiang W; Yang M; Guo H; Zhang Y; Wang J; Zhu H; Shi R; Fan D; Yang C; Zhu Z; Xie Y; Xiong D
J Immunother; 2010 Jun; 33(5):500-9. PubMed ID: 20463597
[TBL] [Abstract][Full Text] [Related]
48. Black TiO
Ren W; Iqbal MZ; Zeng L; Chen T; Pan Y; Zhao J; Yin H; Zhang L; Zhang J; Li A; Wu A
Nanoscale; 2017 Aug; 9(31):11195-11204. PubMed ID: 28749498
[TBL] [Abstract][Full Text] [Related]
49. Lx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivo.
Zhou Q; Li Y; Jin J; Lang L; Zhu Z; Fang W; Chen X
Biol Pharm Bull; 2012; 35(12):2170-9. PubMed ID: 23207769
[TBL] [Abstract][Full Text] [Related]
50. Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate.
Li X; Lu W; Hu Y; Wen S; Qian C; Wu W; Huang P
Int J Oncol; 2013 Nov; 43(5):1710-8. PubMed ID: 23982861
[TBL] [Abstract][Full Text] [Related]
51. DNAzyme-Loaded Metal-Organic Frameworks (MOFs) for Self-Sufficient Gene Therapy.
Wang H; Chen Y; Wang H; Liu X; Zhou X; Wang F
Angew Chem Int Ed Engl; 2019 May; 58(22):7380-7384. PubMed ID: 30916460
[TBL] [Abstract][Full Text] [Related]
52. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer.
Liu P; Liu X; Cheng Y; Zhong S; Shi X; Wang S; Liu M; Ding J; Zhou W
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53654-53664. PubMed ID: 33205940
[TBL] [Abstract][Full Text] [Related]
53. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
54. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.
Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM
Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771
[TBL] [Abstract][Full Text] [Related]
55. Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.
Li H; Zhang G; Jiang C; Zhang F; Ke C; Zhao H; Sun Y; Zhao M; Chen D; Zhu X; Zhang L; Li B; Dai J; Li W
Oncotarget; 2015 Sep; 6(27):24192-204. PubMed ID: 26284588
[TBL] [Abstract][Full Text] [Related]
56. Metal-Organic Framework/Ag-Based Hybrid Nanoagents for Rapid and Synergistic Bacterial Eradication.
Yang Y; Wu X; He C; Huang J; Yin S; Zhou M; Ma L; Zhao W; Qiu L; Cheng C; Zhao C
ACS Appl Mater Interfaces; 2020 Mar; 12(12):13698-13708. PubMed ID: 32129070
[TBL] [Abstract][Full Text] [Related]
57. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
Gründker C; Wokoun U; Hellriegel M; Emons G
J Obstet Gynaecol Res; 2019 Jul; 45(7):1334-1342. PubMed ID: 31016845
[TBL] [Abstract][Full Text] [Related]
59. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
[TBL] [Abstract][Full Text] [Related]
60. Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis.
Li X; Yu N; Li J; Bai J; Ding D; Tang Q; Xu H
ACS Appl Mater Interfaces; 2020 Mar; 12(9):10096-10106. PubMed ID: 32027119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
